Correlation Between 516220 and Nanhua Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 516220 and Nanhua Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 516220 and Nanhua Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 516220 and Nanhua Bio Medicine, you can compare the effects of market volatilities on 516220 and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 516220 with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of 516220 and Nanhua Bio.

Diversification Opportunities for 516220 and Nanhua Bio

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between 516220 and Nanhua is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding 516220 and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and 516220 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 516220 are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of 516220 i.e., 516220 and Nanhua Bio go up and down completely randomly.

Pair Corralation between 516220 and Nanhua Bio

Assuming the 90 days trading horizon 516220 is expected to under-perform the Nanhua Bio. But the etf apears to be less risky and, when comparing its historical volatility, 516220 is 2.22 times less risky than Nanhua Bio. The etf trades about 0.0 of its potential returns per unit of risk. The Nanhua Bio Medicine is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,078  in Nanhua Bio Medicine on September 12, 2024 and sell it today you would lose (28.00) from holding Nanhua Bio Medicine or give up 2.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

516220  vs.  Nanhua Bio Medicine

 Performance 
       Timeline  
516220 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in 516220 are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 516220 sustained solid returns over the last few months and may actually be approaching a breakup point.
Nanhua Bio Medicine 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

516220 and Nanhua Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 516220 and Nanhua Bio

The main advantage of trading using opposite 516220 and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 516220 position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.
The idea behind 516220 and Nanhua Bio Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk